Quick Takeaways
- Allan Camaisa has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $111,965.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Allan Camaisa
- Location
- San Diego, CA
- Summary
- The estimated net worth of Allan Camaisa is at least $111,965 dollars as of 16 Dec 2025. Allan Camaisa is the Director of Calidi Biotherapeutics, Inc. and owns shares of Calidi Biotherapeutics, Inc. (CLDI) stock worth about $112K.
- Signature
- /s/ Andrew Jackson, Attorney-in-fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Allan Camaisa and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Calidi Biotherapeutics, Inc. ($111,965).
- Past-year value change for that position: -$1,237.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Allan Camaisa
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| CLDI, CLDWW | Calidi Biotherapeutics, Inc. | Director | $111,965 | -$1,237 | -1.1% | 12 Dec 2025 |
Insider Transactions Reported by Allan Camaisa:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.